 Akcea Therapeutics NASDAQ:AKCAs stock had its hold rating reiterated by analysts at Cowen in a research report issued on Sunday, AnalystRatings.com reports. A number of other brokerages have also recently weighed in on AKCA. TheStreet cut shares of Akcea Therapeutics from a c- rating to a d rating in a research report on Tuesday, May ... 